Agios Pharmaceuticals Files Q1 2025 10-Q
Ticker: AGIO · Form: 10-Q · Filed: May 1, 2025 · CIK: 1439222
| Field | Detail |
|---|---|
| Company | Agios Pharmaceuticals, Inc. (AGIO) |
| Form Type | 10-Q |
| Filed Date | May 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Agios Q1 2025 10-Q filed. Check financials.
AI Summary
Agios Pharmaceuticals, Inc. reported its first quarter 2025 results for the period ending March 31, 2025. The company's filing details its financial position and operational highlights. Specific financial figures and operational details are available within the full 10-Q report.
Why It Matters
This filing provides investors with a quarterly update on Agios Pharmaceuticals' financial health and operational progress, crucial for investment decisions.
Risk Assessment
Risk Level: medium — Quarterly filings for pharmaceutical companies often contain complex financial data and potential regulatory updates that can impact stock value.
Key Numbers
- 2025-03-31 — End of Reporting Period (Financials are reported as of this date.)
- 2025-01-01 — Start of Reporting Period (Financials cover the period from this date.)
Key Players & Entities
- AGIOS PHARMACEUTICALS, INC. (company) — Filer
- 20250331 (date) — Conformed Period of Report
- 20250501 (date) — Filed as of Date
- CAMBRIDGE (location) — Business Address City
- 617-649-8600 (phone_number) — Business Phone
FAQ
What is the company's primary business activity?
Agios Pharmaceuticals, Inc. is classified under Pharmaceutical Preparations [2834].
What is the filing date of this 10-Q report?
This 10-Q report was filed on 20250501.
What is the fiscal year end for Agios Pharmaceuticals, Inc.?
The fiscal year end for Agios Pharmaceuticals, Inc. is December 31.
What is the SEC file number for Agios Pharmaceuticals, Inc.?
The SEC file number is 001-36014.
What is the business address of Agios Pharmaceuticals, Inc.?
The business address is 88 Sidney Street, Cambridge, MA 02139.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding AGIOS PHARMACEUTICALS, INC. (AGIO).